Interventional approaches to treatment resistant depression (DTR) in children and adolescents: A systematic review and meta-analysis.
Ethan Faries, Landon A Mabe, Ronald L Franzen, Syed Murtaza, Komal Nathani, Burhan Ahmed, Larry J. Prokop, Khaled Mohammed, Ahmed T Ahmed
Journal of Affective Disorders December 15, 2024 DOI: 10.1016/j.jad.2024.08.212 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review and meta-analysis Randomized Peer reviewed |
|---|---|
| Population | Adolescents and youth aged 10-24 with treatment-resistant depression |
| Interventions | Electroconvulsive Therapy repetitive Transcranial Magnetic Stimulation ketamine |
| Topics | Depression Ketamine |
| Keywords | Ect Interventional psychiatry Treatment resistant Rtms Depression treatment Youth mental health Brain stimulation therapy Psychiatric interventions |
| Citations | 13 |
| Key findings | rTMS resulted in significantly larger reductions in depression scores than ECT and potentially larger reductions than ketamine in youth with treatment-resistant depression. |
Abstract
Major depressive disorder (MDD) is highly prevalent in youth. Conventional treatment paradigms primarily involve selective serotonin reuptake inhibitors (SSRIs) and psychotherapy, yet a significant proportion of this population exhibits treatment-resistant depression (TRD). In adults, interventional therapies like Electroconvulsive Therapy (ECT), repetitive Transcranial Magnetic Stimulation (rTMS), and ketamine have shown promise for TRD, but their comparative efficacy remains underexplored in Adolescent and pediatric population. This systematic review and meta-analysis aims to assess the relative effectiveness of ECT, rTMS, and ketamine in treating TRD among adolescents. Following PRISMA guidelines, we systematically searched databases for studies of ECT, rTMS, or ketamine for treatment-resistant depression in youth ages 10-24. Three reviewers independently screened for inclusion based on predefined criteria. Included observational and randomized controlled trials reported depression symptoms with measures like HDRS and MADRS in youth treated with ECT, rTMS, or ketamine. Two reviewers extracted data on interventions, patients, and depression symptom outcomes. Chance-adjusted inter-reviewer agreement was calculated. For meta-analysis, we pooled standardized mean differences (SMDs) in depression scores using random effects models and assessed heterogeneity with I2 statistics. Meta-analysis of 10 observational studies examined SMD in depression scores for treatment resistant depression patients treated with ECT, ketamine, or rTMS. Patients treated with ECT had a significantly lower SMD of 1.99 (95 % CI 0.92-3.05, p 0.05). Comparative analysis between ECT and ketamine found no significant difference in SMD (p = 0.387). Comparison of ECT versus rTMS found a significant difference in SMD favoring rTMS (p = 0.004). Comparison of ketamine versus rTMS suggested a potential difference in SMD favoring rTMS (p = 0.058). In summary, rTMS resulted in significantly larger reductions in depression scores than ECT, and potentially larger reductions than ketamine. This meta-analysis illustrates the ability of rTMS, ECT, and ketamine to improve depression in youth. rTMS resulted in the largest improvements, highlighting its potential as a first-line treatment for pediatric treatment-resistant depression given its favorable side effect profile compared to ECT. Further research directly comparing these modalities is needed.
Comparable studies
Other systematic reviews and meta-analyses on ketamine for depression, most cited first.